Search All UT System Experts

Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China

Linong Ji, A. J. Ahmann, B. Ahrén, M. S. Capehorn, P. Hu, I. Lingvay, W. Liu, H. W. Rodbard, Z. Shen, C. Sorli

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China'. Together they form a unique fingerprint.

Medicine & Life Sciences